New Delhi, July 20: India has approved QDENGA, the country’s first dengue vaccine, for people aged 4 to 60 years, marking an important step towards strengthening dengue prevention and healthcare efforts.
The approval introduces a new preventive measure against dengue, a mosquito-borne disease that continues to pose a public health challenge in several parts of the country. The vaccine is expected to support efforts to reduce the impact of dengue infections among eligible age groups.
Health experts said vaccination, along with existing preventive measures such as mosquito control, maintaining hygiene, and early detection of symptoms, will be important in managing the spread of dengue.
The availability of QDENGA is expected to provide an additional layer of protection for communities and support India’s broader efforts to improve public health preparedness against mosquito-borne diseases.
The approval marks a significant milestone in dengue prevention and highlights continued progress in strengthening healthcare solutions in India.
